CD2AP Antibodies

Santa Cruz Biotechnology features a diverse variety of CD2AP monoclonal antibodies for investigating CD2-associated protein. CD2AP monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD2AP is a crucial adaptor protein involved in the regulation of cell signaling and cytoskeletal organization, playing a significant role in immune responses and cellular adhesion. CD2AP has been linked to various diseases, including kidney disorders and certain cancers, making it an important target for therapeutic research. Understanding CD2AP function can provide insights into cellular processes and disease mechanisms. CD2AP research has revealed its essential role in maintaining podocyte function and glomerular filtration barrier integrity. CD2AP studies have demonstrated its involvement in T-cell activation and immune synapse formation. CD2AP investigation continues to uncover new pathways and mechanisms in cellular signaling. Santa Cruz Biotechnology monoclonal antibodies for CD2AP research support scientists in advancing our understanding of cellular processes and disease mechanisms.